Cargando…
Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation
TCR diversity measures are often used to understand the immune response in cancer. Traditional measures of diversity rely on bulk RNA sequencing (RNAseq) of the β-chain variable regions. However, the full αβ TCR repertoire is a combination of both the α- and β-chains, which are encoded by separate g...
Autores principales: | Muhowski, Elizabeth M., Rogers, Laura M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AAI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354877/ https://www.ncbi.nlm.nih.gov/pubmed/37129560 http://dx.doi.org/10.4049/immunohorizons.2200062 |
Ejemplares similares
-
Should we reconsider how to assess eutrophication?
por: Polimene, L, et al.
Publicado: (2023) -
Pre-existing T Cell Memory to Novel Pathogens
por: Afroz, Sumbul, et al.
Publicado: (2023) -
How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System
por: Raines, Lydia N., et al.
Publicado: (2023) -
TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology
por: Tsagaratou, Ageliki
Publicado: (2023) -
Both Horatio and Polonius: Innate Lymphoid Cells in Tissue Homeostasis and Repair
por: Lee, Intelly S., et al.
Publicado: (2023)